scholarly journals Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures

2012 ◽  
Vol 27 (3) ◽  
pp. 672-678 ◽  
Author(s):  
Eve Donnelly ◽  
Dennis S Meredith ◽  
Joseph T Nguyen ◽  
Brian P Gladnick ◽  
Brian J Rebolledo ◽  
...  
2017 ◽  
Vol 114 (33) ◽  
pp. 8722-8727 ◽  
Author(s):  
Ashley A. Lloyd ◽  
Bernd Gludovatz ◽  
Christoph Riedel ◽  
Emma A. Luengo ◽  
Rehan Saiyed ◽  
...  

Bisphosphonates are the most widely prescribed pharmacologic treatment for osteoporosis and reduce fracture risk in postmenopausal women by up to 50%. However, in the past decade these drugs have been associated with atypical femoral fractures (AFFs), rare fractures with a transverse, brittle morphology. The unusual fracture morphology suggests that bisphosphonate treatment may impair toughening mechanisms in cortical bone. The objective of this study was to compare the compositional and mechanical properties of bone biopsies from bisphosphonate-treated patients with AFFs to those from patients with typical osteoporotic fractures with and without bisphosphonate treatment. Biopsies of proximal femoral cortical bone adjacent to the fracture site were obtained from postmenopausal women during fracture repair surgery (fracture groups, n = 33) or total hip arthroplasty (nonfracture groups, n = 17). Patients were allocated to five groups based on fracture morphology and history of bisphosphonate treatment [+BIS Atypical: n = 12, BIS duration: 8.2 (3.0) y; +BIS Typical: n = 10, 7.7 (5.0) y; +BIS Nonfx: n = 5, 6.4 (3.5) y; −BIS Typical: n = 11; −BIS Nonfx: n = 12]. Vibrational spectroscopy and nanoindentation showed that tissue from bisphosphonate-treated women with atypical fractures was harder and more mineralized than that from bisphosphonate-treated women with typical osteoporotic fractures. In addition, fracture mechanics measurements showed that tissue from patients treated with bisphosphonates had deficits in fracture toughness, with lower crack-initiation toughness and less crack deflection at osteonal boundaries than that of bisphosphonate-naïve patients. Together, these results suggest a deficit in intrinsic and extrinsic toughening mechanisms, which contribute to AFFs in patients treated with long-term bisphosphonates.


2013 ◽  
Author(s):  
Andreas Bernhard ◽  
Petar Milovanovic ◽  
Michael Hahn ◽  
Danijela Djonic ◽  
Matthias Krause ◽  
...  

Bone ◽  
2009 ◽  
Vol 44 ◽  
pp. S372-S373
Author(s):  
K.K. Nishiyama ◽  
H.M. Macdonald ◽  
H.R. Buie ◽  
D.A. Hanley⁎ ◽  
S.K. Boyd

Bone ◽  
2009 ◽  
Vol 44 ◽  
pp. S96-S97
Author(s):  
K.K. Nishiyama ◽  
H.M. Macdonald ◽  
H.R. Buie ◽  
D.A. Hanley ◽  
S.K. Boyd

1995 ◽  
Vol 15 (3) ◽  
pp. 124-128 ◽  
Author(s):  
E. Lea Watson ◽  
R.V. Katz ◽  
R. Adelezzi ◽  
Helen C. Gift ◽  
S.M. Dunn

2013 ◽  
Vol 88 (1) ◽  
pp. 46-55 ◽  
Author(s):  
Pilar Peris ◽  
Elizabeth J. Atkinson ◽  
Mario Gössl ◽  
Trevor L. Kane ◽  
Louise K. McCready ◽  
...  

Maturitas ◽  
2017 ◽  
Vol 100 ◽  
pp. 156
Author(s):  
Evaggelia Karopoulou ◽  
Areti Augoulea ◽  
Ioannis Triantafyllopoulos ◽  
Demetrios Rizos ◽  
Eleni Armeni ◽  
...  

2008 ◽  
Vol 82 (3) ◽  
pp. 182-190 ◽  
Author(s):  
Hiroshi Kaji ◽  
Mika Yamauchi ◽  
Kazuo Chihara ◽  
Toshitsugu Sugimoto

Sign in / Sign up

Export Citation Format

Share Document